Researchers conducted a randomized trial to see if using electronic questionnaires could improve care for patients starting oral anticancer medications. The study involved 388 patients who were split into two groups: one receiving the electronic monitoring and another receiving standard care.
The results showed that while the overall group did not show significant differences in intervention timing, a specific subset of patients who completed the questionnaires saw different results. For these responders, the electronic system led to faster pharmacist interventions and more frequent check-ins. These patients also had lower rates of healthcare utilization compared to those who did not use the system.
It is important to note that the study had a low response rate for the questionnaires. Because the positive results were only seen in the group that completed the surveys, it is unclear if this method works for everyone. Patients should talk to their doctors about how electronic monitoring might fit into their specific treatment plan.